These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 21116787

  • 1. Biowaiver extension potential and IVIVC for BCS Class II drugs by formulation design: Case study for cyclosporine self-microemulsifying formulation.
    Yang SG.
    Arch Pharm Res; 2010 Nov; 33(11):1835-42. PubMed ID: 21116787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs.
    Zhang N, Zhang W, Jin Y, Quan DQ.
    Pharm Dev Technol; 2011 Aug; 16(4):415-21. PubMed ID: 20433250
    [Abstract] [Full Text] [Related]

  • 5. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs.
    Yi T, Wan J, Xu H, Yang X.
    Eur J Pharm Biopharm; 2008 Oct; 70(2):439-44. PubMed ID: 18603415
    [Abstract] [Full Text] [Related]

  • 6. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R.
    Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
    Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G.
    Int J Pharm; 2009 Apr 17; 371(1-2):148-55. PubMed ID: 19124065
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP.
    Drug Dev Ind Pharm; 2009 May 17; 35(5):603-11. PubMed ID: 19040178
    [Abstract] [Full Text] [Related]

  • 11. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
    Kees F, Bucher M, Schweda F, Gschaidmeier H, Burhenne J, Mikus G, Faerber L.
    Ther Drug Monit; 2006 Jun 17; 28(3):312-20. PubMed ID: 16778713
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
    Xiumin LI, Man GE, Minzi LU, Yinghua J, Dongqin Q.
    Curr Drug Deliv; 2015 Jun 17; 12(3):308-13. PubMed ID: 26054534
    [Abstract] [Full Text] [Related]

  • 18. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation.
    Tsume Y, Amidon GL.
    Mol Pharm; 2010 Aug 02; 7(4):1235-43. PubMed ID: 20557130
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride.
    Zhu JX, Tang D, Feng L, Zheng ZG, Wang RS, Wu AG, Duan TT, He B, Zhu Q.
    Drug Dev Ind Pharm; 2013 Mar 02; 39(3):499-506. PubMed ID: 22563917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.